Beck, Lisa, Ann, MD

Lisa A. Beck, MD is a highly experienced dermatologist with over 20 years of expertise in treating atopic dermatitis and eczema. She is currently involved in an NIH-funded study to understand the susceptibility of certain patients to herpes simplex and Staphylococcus aureus viruses. Dr. Beck is a professor in the Department of Dermatology at the University of Rochester Medical Faculty Group and holds faculty appointments in several other departments. She has been recognized for her contributions to dermatology research and has played a pivotal role in the development of the first biologic drug for eczema treatment.

Dr. Beck's research focuses on finding safe and effective treatments for patients with atopic dermatitis. She is internationally recognized as an eczema expert and has been instrumental in the development of the biologic drug, Dupixent. As the Co-Director of the URMC Center for Allergic Disease Research, she leads efforts to understand the susceptibility of eczema patients to viral and bacterial infections. Dr. Beck has been funded by the NIH since 1992 and has completed numerous clinical trials and research studies. Her dedication to advancing dermatology knowledge and improving patient care has earned her prestigious awards and leadership positions in professional organizations.

Generated from the website